Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

A yearly injection such as Lenacapavir could help overcome barriers to PrEP accessibility by increasing its uptake and making ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Camp Dreamcatcher in Chester County, launched at the height of ‘90s stigma around HIV, has served thousands of children ...

When volunteers launched Pittsburgh Aids Task Force in 1985, they didn’t expect the organization would be operating 40 years later.

The President of the HIV/AIDS Network, Ernest Amoabeng Ortsin, has lamented the government’s role in the fight against ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

PEPFAR, a global program to combat AIDS, faces an existential threat due to partisan politics, but Congress has an ...

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

Hundreds of HIV doctors and researchers have called on the Trump administration to reverse its sweeping aid funding cuts, saying they are "doing catastrophic harm" to the global fight against AIDS.

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.